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Abstract
Background: A subset of the Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1SM)
is involved in the cytoadherence of P. falciparum-infected red blood cells (iRBC) contributing to the
pathogenesis of severe disease among young children in malaria endemic areas. The PfEMP1SM are
encoded by group A var genes that are composed of a more constrained range of amino acid
sequences than groups B and C var genes encoding PfEMP1UM associated with uncomplicated
malaria. Also, unlike var genes from groups B and C, those from group A do not have sequences
consistent with CD36 binding – a major cytoadhesion phenotype of P. falciparum isolates.
Methods: A 3D7 PfEMP1SM sub-line (3D7SM) expressing VAR4 (PFD1235w/MAL8P1.207) was
selected for binding to CD36. The protein expression of this parasite line was monitored by surface
staining of iRBC using VAR4-specific antibodies. The serological phenotype of the 3D7SM parasites
was determined by flow cytometry using malaria semi-immune and immune plasma and
transcription of the 59 var  genes in 3D7 were analysed by real-time quantitative reverse
transcriptase-polymerase chain reaction (RT-PCR) using var-specific primers.
Results: A selection-induced increased adhesion of 3D7SM iRBC to CD36 resulted in a reduced
var4 transcription and VAR4 surface expression.
Conclusion: VAR4 is not involved in CD36 adhesion. The current findings are consistent with the
notion that CD36 adhesion is not associated with particular virulent parasite phenotypes, such as
those believed to be exhibited by VAR4 expressing parasites.
Background
Variant surface antigens (VSA) on the Plasmodium falci-
parum-infected red blood cells (iRBC) are involved in
both cytoadherence contributing to disease pathology [1-
8] and immune evasion which probably contributes to
the severity and persistence of malaria infections [9-11].
Anti-VSA antibodies have been shown to contribute to
protective immunity [12-16] and data from several studies
indicate that some important targets for immunity seem
to have restricted heterogeneity.
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The  Plasmodium falciparum Erythrocyte Membrane Pro-
tein-1 (PfEMP1) is the most studied VSA. PfEMP1 mole-
cules are encoded by the var gene family comprising 50–
60 highly diverse genes per haploid genome [17-22]. Any
single parasite nuclei transcribes only one variant at a
time, a phenomenon referred to as allelic exclusion or
mutually exclusive expression [20,23-26]. Cultures of
unselected 3D7 parasites predominantly express PfEMP1
mRNA species resembling those of parasites causing
uncomplicated malaria (PfEMP1UM). The dominant sero-
logical phenotype (recognition by semi-immune and
immune human plasma) changes to PfEMP1SM following
selection of 3D7 using DynaBeads coated with IgG from
semi-immune children [27]. This 3D7SM shows transcrip-
tional upregulation and protein surface expression of one
particular group A var  gene,  var4  (PFD1235w/
MAL8P1.207)[28]. More recently, group A var  genes,
together with certain other B/A type were found to be tran-
scribed in isolates from children with cerebral malaria,
but not from isolates from equally highly parasitaemic
patients without severe malaria syndromes [29].
Group A var genes are one of three major groups (A, B and
C) of 3D7 var gene sequences categorized according to
chromosomal location, gene orientation, domain struc-
ture of the encoded proteins and similarities in coding
and non-coding regions. Group A contains seven genes
encoding large PfEMP1s of about 400 kDa, with complex
domain arrangements and three genes encoding PfEMP1s
of about 150 kDa [30,31]. Unlike most other var genes
from group B and C, the Group A var genes do not encode
sequences thought to be consistent with binding to CD36,
a major endothelial receptor for iRBC sequestration [31].
It should be noted however that the correlation between
severity, binding phenotype and var gene expression is not
clear-cut [4,32].
In this study, changes in the transcription of all var genes
and surface expression levels of VAR4 as a result of drifting
and changes following selection for binding of 3D7SM to
CD36 was investigated.
Methods
Parasites
All parasites used in this study were derived from the P.
falciparum isolate, 3D7 and were cultured in O Rh+ RBCs
as described previously [33]. Three 3D7 sub-lines were
used, namely: 3D7SM-CD36,3D7SM-drift and 3D7UM.
3D7SM-CD36 was obtained by bio-panning 3D7SM on Chi-
nese hamster ovary (CHO) cells expressing CD36. 3D7SM
has previously been selected from 3D7 using a pool of
plasma from semi-immune Ghanaian children [27,28].
To select for a CD36-binding 3D7SM  population, the
method described in [27] was followed. Gelatine enriched
late-stage 3D7SM was panned on a monolayer of wild-type
CHO cells. Unbound iRBC and uninfected RBC (uRBC)
were then panned on CHO cells transfected with human
CD36. The monolayer was washed repeatedly to remove
unbound iRBC and uRBC. To allow bound 3D7SM para-
sites to reinvade and grow, culture medium and uRBC
were added to the monolayer of CD36-transfected CHO
cells and incubated overnight.
3D7SM  was allowed to drift without routine selection
using the Ghanaian plasma pool to obtain the subline
3D7SM-drift. For consistency, 3D7SM-drift  and unselected
3D7 were late-stage enriched by gelatine flotation [34]
every time 3D7SM-CD36 was selected for CD36 binding. The
gelatine-enriched unselected 3D7 was termed 3D7UM and
was serologically similar to parasites causing uncompli-
cated malaria [27].
The genotypic identity of the 3D7 isolate and its derived
sub-lines were confirmed by PCR at the polymorphic
msp1, msp2, and glurp loci [35].
Immuno-staining of live cells and flow cytometry
Immuno-staining and flow cytometry were carried out as
described [28,33] with minor modifications. To monitor
VAR4 expression on the surface of live cells, late stage-
iRBC were enriched by magnet-activated cell sorting
(MACS, Miltenyl BioTec, Bergisch Gladbach, Ger-
many)[36,37]. MACS purified and ethidium bromide-
labeled iRBC (2.5 × 105) was incubated for 1 hr in 20 μL
mouse sera or 40 μL rabbit sera raised against the CIDR1α
or DBL5δ domains of VAR4[28] depleted for anti-human
RBC antibodies prior to use. To detect surface bound anti-
bodies, the iRBC were sequentially exposed to 100 μL of
1:25 goat anti-mouse or anti-rabbit Ig (DAKO), bioti-
nylated anti-goat Ig (DAKO) and 1:1,000 fluorescein iso-
thiocyanate (FITC)-conjugated streptavidin (BD
Pharmingen) for 30 minutes each. For serological pheno-
typing, 20 human plasma samples from Magoda village in
Tanzania with high malaria transmission were used to
determine the recognition profile of the various parasite
lines. Out of the 20 Magoda plasma samples, 10 came
from children aged 3–5 years and 10 came from adoles-
cents and adults aged 12–63 years. Staining of the iRBC by
human IgG was done by incubating 2.5 × 105 MACS puri-
fied ethidium bromide-labeled iRBC in 5 μL human
plasma for 30 minutes and then sequentially exposed to
100  μL of 1:50 biotinylated rabbit anti-human IgG
(DAKO) and 1:2000 FITC-conjugated streptavidin
(DAKO) for 30 minutes each. All immuno-stained sam-
ples were analysed in a Coulter EPICS XL-MCL flow
cytometer (Coulter Electronics, Luton, UK) or in a FACS-
can (Becton Dickinson). Data were analysed in WinMDI
software http://facs.scripps.edu/software.html and Win-
List version 5.0 (Verity Software House, Inc., Maine, USA).Malaria Journal 2008, 7:204 http://www.malariajournal.com/content/7/1/204
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Student's t-test was used to determine whether the sam-
ples compared were significantly different (P = ≤0.05).
RNA extraction, cDNA synthesis and Quantitative Real-
Time PCR
RNA extraction, cDNA synthesis and quantitative real-
time PCR were done as previously described [28,38]. Tro-
phozoite/schizont-iRBC (36–48 h after invasion) were
isolated from mixed stage in vitro cultures by exposure to
a strong magnetic field as described in the previous sec-
tion. To obtain ring stage parasites (30 h), the late stage
enriched iRBC were cultured overnight. The ring stage has
previously been shown to be optimal for studies of var
gene transcription [38] and is therefore used for RNA
extraction. Total RNA was purified using Trizol (Invitro-
gen) and treated with DNAseI (Invitrogen) for 15 min at
37°C. Superscript II was used to reverse transcribe DNA-
free RNA primed with random hexamer primers (Invitro-
gen) at 25°C for 10 min, 42°C for 50 min followed by
70°C for 15 min. Quantitative real-time PCR was done
using a Rotorgene thermal cycler system (Corbett
Research, Motlake, Australia) and real-time PCR-opti-
mized and gene-specific primers for each of the 59 full-
length var genes in the P. falciparum 3D7 genome [28,38].
Reactions were performed in 20 μl volumes using Quant-
iTect SYBR Green PCR master mix (Qiagen, Merck Euro-
lab, Albertslund, Denmark) and 1 μM primers.
Quantification was done using Rotorgene software ver-
sion 4.6. The housekeeping gene seryl-tRNA synthetase,
which shows a uniform transcription profile in different
parasite isolates and an unchanged pattern throughout
the parasite life cycle, was used as an endogenous control
as previously described [38] and used for calculations of
percent measured transcript out of total var transcipts by
the ΔΔCT method (User Bulletin no. 2, Applied Biosys-
tems).
CD36 binding assay
The CD36 binding assay was done as described in detail
elsewhere [27]. To radiolabel parasites, cultures were
incubated overnight in 10% non-immune Danish plasma
in RPMI 1640 in the presence of 3H-hypoxanthine. Mon-
olayers of wild type, CD36- and CD54-transfected CHO
cells and transformed human bone marrow endothelial
cells (TrHBMEC) were grown in 96-well microtiter plates
(Nunc, Roskilde, Denmark). Late stage enriched iRBC
(100 μl, 1 × 107 iRBC/ml) were added to the CHO cell
monolayer and incubated for 1 hour at 37°C. After
removal of unbound iRBC, the number of iRBCs adhering
to the CHO cells was determined by liquid scintillation
spectrometry.
Results
Reduced expression of VAR4 following selection for CD36 
binding
To determine the effect of CD36 selection on VAR4 sur-
face expression, mouse or rabbit antibodies against the
CIDR1α domain of VAR4 were used to stain three 3D7
sub-lines – 3D7UM, 3D7SM-CD36 and 3D7SM-drift and the
parasite protein surface expression subsequently analysed
by flow cytometry (Figure 1A). In agreement with what
has been previously shown [28], 3D7SM surface expressed
VAR4, whereas 3D7UM did not show any surface staining
for VAR4 at the beginning of the experiment (Figure 1i-A).
Similarly 3D7SM showed high var4 transcription, whereas
3D7UM only transcribed var4 at a very low level (Figure 1i-
B).
As a control, the VAR4 expressing 3D7SM was left in cul-
ture for 44 generations from the day of the last antibody
selection with gelatine flotation being carried out approx-
imately every nine generations resulting in the 3D7SM-drift
sub-line. Both 3D7SM-CD36 and 3D7SM-drift expressed VAR4
on the surface all throughout the experiment, but with the
3D7SM-CD36 sub-line showing a reduced level from the
third panning (Figure 1ii-A and Figure 2). However, this
reduction in VAR4 surface expression is not statistically
significant (p = 0.19, Figure 2). Following the fifth selec-
tion, VAR4 surface expression was borderline significantly
lower in 3D7SM-CD36 compared with that in 3D7SM (p =
0.05, Figure 2). Similarly, var4 gene transcription in the
3D7 sublines following the fifth selection was markedly
lower in 3D7SM-CD36 (10%) as compared to the level of
transcription in 3D7SM (28%) (Figure 1iii-B). By contrast
the transcription level of the group B/A var  gene
PFF0010w  (formerly known as MAL6P1.316)remained
the same for both sub-lines (3D7SM-drift and 3D7SM-CD36)
throughout the entire experiment (Figure 1ii-B and 1iii-
B).
By using Western blotting for detection of VAR4 expres-
sion in 3D7SM-CD36and 3D7SM-drift sub-lines, a distinct 400
kDa VAR4 band was expressed following all selections,
but it was not possible to accurately quantify the amount
of the protein due to the insufficient sensitivity of the
technique. However, the transcriptional data and flow
cytometry of live immuno-stained parasites indicate that
the 3D7SM parasites which bind to CD36 have reduced
levels of VAR4 PfEMP1 surface expression (Figure 1i–iii
and Figure 2).
Increased adhesiveness to CD36
To test whether the CD36 bio-panning increased the
adhesiveness of 3D7SM to the CD36 molecule, 3D7UM,
3D7SM-CD36 and 3D7SM-drift binding assays were done using
CD36 and CD54 (also known as intercellular adhesion
molecule or ICAM-1) expressing CHO cell lines and TrH-Malaria Journal 2008, 7:204 http://www.malariajournal.com/content/7/1/204
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Figure 1 (see legend on next page)
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BMEC. Due to high background adhesion of iRBC to wild
type CHO cells only iRBC showing more than 8% binding
to CHO-CD36 as seen following the third and fifth pan-
ning (Fig 1ii–iiiC) of 3D7SM-CD36 were considered CD36
binders. Increased binding of 3D7SM-CD36 to CD36 corre-
lated well with reduced VAR4 expression and gene tran-
scription (Figure 1A to 1C and Figure 2). The adhesion of
3D7SM-drift to the CHO-CD36 was low in all selections
(Figure 1iC–iiiC). Binding of 3D7SM-CD36 to CHO-CD54
or TrHMBEC following bio-panning on CD36 did not dif-
fer from that of 3D7SM-drift, indicating that bio-panning on
CD36 was specifically selecting for parasites binding to
the CD36 receptor.
Serological phenotypes of 3D7SM selected for CD36 
binding
Consistent with previous published data [27,28], unse-
lected 3D7 predominantly expressed PfEMP1UM and were
better recognized by adults (12–63 years) than by chil-
dren (3–5 years) (p < 0.0001) while 3D7SM selected using
IgG from semi-immune children was equally well recog-
nized by plasma from both groups of individuals (p = 0.8)
(Figure 1i-D). Three to five rounds of gelatine flotation of
3D7UM did not change the recognition pattern of this sub-
line (data not shown). Following the third round of selec-
tion 3D7SM-drift and 3D7SM-CD36 had similar phenotypes to
that of the original 3D7SM (Figure 1i–iiD). Both sub-lines
became significantly better recognized by adult plasma
than by children's plasma after the fifth round (44 gener-
ations) of gelatine flotation (p = 0.02) or CD36 selection
(p = 0.04, Figure 1iiiD) having serological profiles corre-
lating slightly better with the baseline 3D7UM compared to
the 3D7SM. Although borderline, this would indicate that
both 3D7SM-drift and 3D7SM-CD36 have gradually shifted
from expressing PfEMP1SM-type antigens to expressing
PfEMP1UM-type antigens.
Stability of VAR4 surface expression in 3D7SM left to drift
In the absence of CD36 selection VAR4 is stably expressed
on the surface of 3D7SM-drift for 44 generations – equiva-
lent to five rounds of gelatine flotation (Figure 1iii-A). To
analyse this further 3D7UM and 3D7SM were cultured with-
out gelatine flotation or CD36 selection and monitored
VAR4 surface expression and var4 transcription at speci-
fied time points for 94 generations. To avoid assay-to-
assay variation, RBC infected with the two parasite sub-
lines were frozen down at each sampling point. Frozen
iRBC were thawed and cultured for another six genera-
tions and then assayed on the same day. Almost no VAR4
surface expression and var4 gene transcription was seen in
the parental 3D7UM, whereas 3D7SM-iRBC showed high
and stable surface expression of VAR4 as well as gene tran-
scription for at least 94 generations (Figure 3). Using the
percentageVAR4 positive iRBC and the ring-stage var4
transcription level at generation six (first sampling point)
and 94 (last sampling point) the switch off-rate was calcu-
lated to be less than 0.005% (Figure 3). Alternatively, with
a switch off-rate that is virtually 0, the minor differences
observed at the transcription level may simply be due to
experimental errors. Parallel to this, the two 3D7 sub-lines
without prior freezing and thawing were assayed at every
~9th generation and similarly found VAR4 expression and
transcription to be stable for over six months in continu-
ous in vitro culture.
Discussion
A previous study has shown that var4, a group A var gene,
is highly transcribed and surface expressed in 3D7 para-
sites expressing PfEMP1SM  (3D7SM) compared to 3D7
expressing PfEMP1UM (3D7UM), suggesting an association
between VAR4 and severe malaria [28]. CD36 binding has
in some studies been associated with disease severity. In a
study in Kenya, a mutation in the CD36 gene among chil-
dren has been associated with protection from severe
malaria [39]. In addition, P. falciparum isolates from Thai
Serological phenotypes, transcription and adhesion profiles of four 3D7 sub-lines, 3D7SM, 3D7UM, 3D7SM-drift and 3D7SM-CD36 Figure 1 (see previous page)
Serological phenotypes, transcription and adhesion profiles of four 3D7 sub-lines, 3D7SM, 3D7UM, 3D7SM-drift and 
3D7SM-CD36. Panel (i): Parental 3D7UM and 3D7SM, 3D7SM-drift and 3D7SM-CD36 at the beginning of the experiment and following 
three (ii) and five (iii) rounds of gelatine flotation or selections for binding to CD36. Panel (A) shows the surface expression of 
VAR4 (open histograms) detected by flow cytometry using VAR4 anti-CIDR1α mouse (i) and rabbit anti-CIDR1α sera (ii and 
iii). Reactivity with pre-immunisation sera is shown for comparison (shaded histograms). Histograms are from one out of three 
replicate assays described in the Figure 2 legend. Panel (B) shows the total percentage of ring-stage transcripts of each var gene 
group out of total var transcripts (black bars). Grey bars show the percentage transcription of var4 and PFF0010w a group A 
and B/A gene highly upregulated in the 3D7SM compared to the 3D7UM sub-line. Panel C shows the percentage of iRBC adher-
ing to wild type and CD36-transfected Chinese hamster ovary cells (CHO) compared with the total number of iRBC added to 
the plate. Bars are means of triplicate wells showing standard deviations and p values. Panel D shows t-tests comparing the rec-
ognition (average mean fluorescence intensities, MFI) of the different parasite sub-lines by plasma from 10 children (3–5 years) 
and 10 adults (12–63 years). The 95% confidence interval, standard deviations, outliers and p values are shown. p values ≤ 0.05 
were considered significantly different. The cut-off (reference line) was defined as the mean MFI values obtained using plasma 
from three Danish donors never exposed to malaria plus two times standard deviation.Malaria Journal 2008, 7:204 http://www.malariajournal.com/content/7/1/204
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adults suffering from severe but not cerebral malaria had
higher CD36 adhesion than those from uncomplicated
malaria patients [40]. In contrast, several studies are con-
sistent with the notion that CD36 binding is not associ-
ated with particular virulent parasite phenotypes
[27,28,30-32,41-43]. Robinson et al [31] has demon-
strated in a heterologous expression assay that the CIDR1
region of VAR4 did not bind to CD36. There might be a
conformational difference between the heterologous
recombinant protein and the native protein presented on
the iRBC or binding could be through a different domain.
However, it remains that the current data on VAR4 expres-
sion on iRBC and CD36 binding phenotype support the
prediction made by Robinson et al [31]. The current study
has shown that VAR4 protein expression and var4 mRNA
transcription are reduced following selection for CD36
binding, lending further support to the hypothesis that
PfEMP1SM antigens such as VAR4 are not involved in
CD36 binding.
However, it is important to note that the correlation
between severe malaria, the inability to bind to CD36 and
group A var gene expression is not clear-cut [4,31]. ICAM-
1 binding may be associated with cerebral malaria as
shown by previous studies [43-45]. But as demonstrated
by Smith et al [4], at least two group B PfEMP1 that bind
to ICAM-1 also bind to CD36. In addition, not all severe
malaria isolates express group A var genes [42].
Selection of 3D7SM for binding to CD36 lead to a reduced
var4 gene transcription, but did not show any significant
changes in other var genes as such. PFF0010w, a group B/
VAR4 surface expression in 3D7SM-drift and 3D7SM-CD36 in 3 replicate experiments correlated with CD36 adhesion Figure 2
VAR4 surface expression in 3D7SM-drift and 3D7SM-CD36 in 3 replicate experiments correlated with CD36 adhe-
sion. Left Y-axis, solid circles show mean percent VAR4 positives of 3D7SM-drift and 3D7SM-CD36 following three (3×) and five 
(5×) rounds of gelatine flotation or selections for binding to CD36 of three replicate experiments. Standard deviations are 
shown as error bars. The 3D7 sublines were not frozen nor thawed for the first replicate experiment prior to determination 
of VAR4 surface expression. For the second and third replicate experiments there was prior freezing, thawing, and in vitro cul-
ture of the 3D7 sublines. p values ≤ 0.05 were considered significantly different. Right Y-axis, open circles show adhesion ratio 
of the different 3D7 sublines. Adhesion ratio is calculated as percent adhesion to CHO-CD36 over percent adhesion to CHO-
wild type.
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A var gene upregulated in 3D7SM together with var4 was
previously predicted to be a non-CD36 binder based on
its CIDR1 sequence [31]. In the current study however,
selection on CD36 did not reduce PFF0010w transcription
as would be expected. The reason for this is that
PFF0010w is probably not expressed on the surface of
3D7SM parasites as indicated by one distinct population of
VAR4 expressing parasites in 3D7SM and 3D7SM-drift (Figure
1i–iiiA). Previous studies have shown that only one
PfEMP1 is expressed on the surface at a time [24,46] so
these VAR4 expressing parasites are less likely to be
expressing PFF0010w. However, a PFF0010w-specific
antibody is needed to confirm this.
Although Group B and C var genes have been linked to
CD36 binding [30,31], new protein bands were not
detected in 3D7SM-CD36 using Western blots and anti-ATS
antibodies compared to the protein band pattern seen in
extracts of 3D7SM. Furthermore, the serological phenotype
of 3D7SM-drift and 3D7SM-CD36remained similar when ana-
lysed by flow cytometry. These results might be explained
by the fact that only 8% of the 3D7SM-CD36 parasites bound
to the CD36 receptor while transcription and serological
analysis was done on the entire parasite population. With
the present set up it is difficult to determine the exact var
genes involved in the CD36 adhesion of 3D7SM-CD36
although a slight increase in the total transcription level of
group B var genes was noted in this sub-line at the end of
the experiment (Figure 1iii-B). In order to determine the
PfEMP1 involved in CD36 binding, both transcription
and protein expression data are required.
Var gene transcription does not always reflect phenotypic
expression as observed in this study, where VAR4 protein
expression was poorly correlated with var4 transcription
after the third CD36 panning (Figure 1ii-A and 1B). How-
ever, the fifth CD36 panning resulted to a higher correla-
tion between var4 transcription and protein expression
(Figure 1iii-A and 1B) most likely due to the more homog-
enous population as indicated by the dominant peak of
VAR4 negative parasites in the histogram (Figure 1iiiA).
Studies have shown that var gene transcription peaks dur-
ing the ring stage at 3–18-hour post invasion [47,48] and
that full length var transcript is not seen at all by Northern
blotting at 24–34-hour post invasion [49]. In the current
study, a 30-hour post invasion ring stage was used to
measure var gene transcription. At 30 hours, the parasites
Changes in VAR4 surface expression and transcription of the 3D7SM subline left to drift (3D7SM-drift) Figure 3
Changes in VAR4 surface expression and transcription of the 3D7SM subline left to drift (3D7SM-drift). Left Y-axis, 
percentage of infected blood cells positive for VAR4 using flow cytometry and VAR4-specific CIDR1α (closed circle) and 
DBL5δ (open triangle) rabbit antibodies. Right Y-axis, percentage var4 gene transcription in ring stage (closed square) parasites 
calculated as: (var4 absolute copy number/∑copy number of all 3D7 var genes) × 100%. Fluorescence of 3D7SM-drift stained with 
pre-immune serum was used to separate positive cells from cells with background fluorescence.
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appeared as non-pigmented thick ring forms under the
microscope. An improved quantification of transcript
abundances of each var gene obtained by quantitative real
time PCR and the use of cross intron primers show that
although the dominant full length transcript peaks at the
ring stage, it remains dominant through out the life cycle
[50].
In the absence of immune pressure var genes have been
reported to have variable transition rates in vitro. There
have been reports of transition rates as low as 0.025% [51]
to as high as 2.4% [52] per generation. In the absence of
CD36 selection and immune pressure, VAR4 surface
expression is stable for more than six months in continu-
ous in vitro culture with a transcription off rate of less than
0.005%. For a PfEMP1 implicated in severe disease and
expected to dominate in a host with limited immunity, it
may not be surprising that VAR4 appears to have a low
switching rate. Frank et al [53] have recently observed that,
in the 3D7 isogenic line NF54, sub-telomeric var genes
have higher off rates of approximately 1% compared with
central var genes with 0 to 0.3% off rates. However, Frank
et al [53] did not observe any activation of upsA genes in
their experiments hence the high switch off rates of the
sub-telomeric var genes reported were that of the upsB pro-
moter type. var4 is a sub-telomeric var gene with an upsA
promoter suggesting the possibility that at least for some
Group A var genes the switch rate might be comparable to
that of central vars.
Both 3D7SM-drift and 3D7SM-CD36 drifted away from a sero-
logical SM phenotype at prolonged in vitro culture to a
more UM like phenotype. However, surprisingly the
3D7SM-drift remained positive for VAR4 surface expression
raising the question whether VAR4 is the only PfEMP1
molecule contributing to the SM phenotype of the origi-
nal antibody selected parasite, 3D7SM. To clarify this, in
the current study, 3D7UM was selected using VAR4 specific
antibodies and found that only some and not all semi-
immune plasma from children recognized 3D7VAR4. This
is an important finding because it points to the possibility
that VSAs other than VAR4 might contribute to the sero-
logical phenotype of 3D7SM.
Conclusion
This study shows that increased CD36 adhesiveness of
3D7SM-CD36resulted in a reduction in VAR4 surface expres-
sion. In the absence of CD36 selection and immune pres-
sure, VAR4 expression by 3D7SM parasites is stable for at
least six months while the population's serological phe-
notype drifts towards the UM phenotype. Results of this
study shed more light on the characteristics of 3D7 para-
sites expressing VAR4 – a PfEMP1 previously associated
with severe malaria phenotypes.
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